G Medical Innovations Holdings Ltd

G Medical Innovations Holdings Ltd. engages in the development of mobile and e-health solutions and monitoring service platforms. It operates through the following segments: Products, Patient Services, and Covid-19 Testing. The Products segment includes the development, manufacture, and marketing of trans-telephonic and wireless diagnostic equipment for the medical industry and consumer market. The Petient Services segment comprises cardiac monitoring services of MCT, Patch, Event, Extended Holter, and Pacemaker. The Covid -19 Testing segment covers three kinds of diagnostic tests which are Rapid Antigen + A/B Flu Combo test, PCR test, and Antibody test. The company was founded in August 2014 and is headquartered in George Town, Cayman Islands.

G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. It operates through the following segments: Products, Patient Services, and Covid-19 Testing, and Kits. The Products segment includes the development, manufacture, and marketing of trans-telephonic and wireless diagnostic equipment for the medical industry and consumer market. The Patient Services segment focuses on cardiac monitoring services of MCT, Patch, Event, Extended Holter, and Pacemaker. The Covid -19 Testing segment covers three kinds of diagnostic tests which are Rapid Antigen + A/B Flu Combo test, PCR test, and Antibody test. The Kits segment engages in direct-To-Customer health testing kits health issues ranging from food sensitivity, indoor/outdoor allergies, HPV, thyroid functioning, testosterone levels, and the hemoglobin A1C test. The company was founded in August 2014 and is headquartered in George Town, Cayman Islands.

The first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies

G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results

Ambev

Color Star Technology

Which trending penny stocks are you watching right now? The post Trending Penny Stocks For Your Watchlist Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trending Penny Stocks For Your Watchlist Next Week

bluebird bio

CYNGN

Here's what you need to know about trading penny stocks on June 21st The post What to Know About Buying Penny Stocks on June 21st  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What to Know About Buying Penny Stocks on June 21st

Irvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a period of 180 calendar days to regain compliance with the minimum bid price requirement. The Notice has no immediate effect on the Company's Nasdaq listing or the trading of its ordinary shares, and during the grace period, as may be extended, the Company's ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol “GMVD”.

G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price Notification

Irvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase program to acquire up to $1 million of the Company's ordinary shares (the “Repurchase Plan”). The Company may purchase ordinary shares from time to time in the open market, through privately negotiated transactions, or any other legally permissible ways, depending on market conditions, share price, trading volume and other factors. Such repurchases shall be made in compliance with the rules of the United States Securities and Exchange Commission (the “SEC”) and other applicable legal requirements. As of May 17th, 2022, the Company had approximately $3 million of cash, $6 million in account receivables and had 24,386,680 ordinary shares outstanding.

G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase Program

TEL AVIV and NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor to purchase 5,000,000 ordinary shares (or ordinary shares equivalents) in a private placement. The Company will also issue to the investor warrants to purchase up to an aggregate of 6,250,000 ordinary shares. The purchase price for one ordinary share and one warrant to purchase one ordinary share is $1.50. The warrants have an exercise price of $1.50 per ordinary share, will be immediately exercisable, and will expire five years from issuance.

(Correction) G Medical Innovations Holdings Ltd Announces $7.5 Million Private Placement

G Medical Innovations Holdings Ltd's (NASDAQ: GMVD) subsidiary, G Medical Tests and Services Inc, expanded its COVID-19 testing services to more than 150+ additional locations across California.  The new testing sites include theme parks, schools, commercial properties,.

G Medical Innovations' Subsidiary Expands COVID-19 Testing To Additional Locations In California

Aridis Pharmaceuticals

Hillstream Biopharma

Splash Beverage Group

Thanks to continued fear and uncertainty, the stock market is down again… The post 4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks Up Big With The Stock Market Down Today; Time To Buy?

The stock price of G Medical Innovations Holdings Ltd (NASDAQ: GMVD) increased by 18.52% in the most recent trading session. This is why it happened.

G Medical Innovations Stock (GMVD): Why The Price Substantially Went Up

HeartBeam

Bluejay Diagnostics

Blackboxstocks

Bridgeline Digital

China Liberal Education Holdings 

Data Storage Corp

Lucid Diagnostics

NeuroBo Pharmaceuticals Inc

Nxt-ID

If you're willing to absorb massive risk for the chance of significant upside, these low-float penny stocks could fit the bill. The post 10 Low-Float Penny Stocks for Steel-Gutted Investors appeared first on InvestorPlace.

10 Low-Float Penny Stocks for Steel-Gutted Investors

Creative Medical Technology Holdings

Lixte Biotech

Leap Therapeutics

Nuverra Environmental Solutions

SeaChange International

Tellurian

Short squeeze penny stocks to watch right now. The post 7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now

The stock price of G Medical Innovations Holdings Ltd (NASDAQ: GMVD) increased by 17.33% today. This is why it happened.

G Medical Innovations Stock (GMVD): Why The Price Surged Today

Will these penny stocks see a short squeeze this week? The post Short Squeeze Penny Stocks To Buy Now?

Short Squeeze Penny Stocks To Buy Now? 4 To Watch Under $5

NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on G Medical Innovations Holdings Ltd. (NASDAQ: GMVD)  Click Here to view full Argus Equity Research Report.

Argus Research Initiates Equity Research Report Coverage on G Medical Innovations Holdings Ltd. (NASDAQ: GMVD)

The Covid-19 crisis has brought a number of changes in the way healthcare providers do business, including the incorporation of digitalization, resulting in a significant rise in the valuations of telehealth companies. The purchase of digital health devices and monitoring systems is becoming more common at a consumer level with the long-term goal of lower healthcare costs.

G Medical Innovations: A Hidden Med-Tech Gem

Auddia

CYREN

Which penny stocks will make the cut for your watchlist this week? The post Top 3 Penny Stocks For Your Weekly Watchlist in September appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top 3 Penny Stocks For Your Weekly Watchlist in September

Demand for patient monitoring services recovering with revenue increasing 45.5% in first half of 2021 Accelerating growth strategy with expansion of Prizma and Cardiac sales team

G Medical Innovations Holdings Ltd. Reports Financial Results for the Six Months Ended June 30, 2021, with Revenue up 45.5%

The stock price of G Medical Innovations Holdings Ltd (NASDAQ: GMVD) increased by over 36% during intraday trading today. This is why it happened.

GMVD Stock: Why It Significantly Increased Today

Photo by Online Marketing on Unsplash If the coronavirus pandemic taught the world anything, it was how important healthcare is to everyone. With the virus still posing a serious threat, some people may still be reluctant to visit their regular doctors for checkups.

G Medical Innovations: The Next Generation of Healthcare for Caregivers and Patients

New York, New York--(Newsfile Corp. - September 8, 2021) - G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, was recently the focus of an article by leading financial news website and publisher, SmallCapsDaily. The article is a thorough synopsis of G Medical's positioning within the healthcare industry, more specifically, the mobile health or "mHealth" sector....

SmallCapsDaily: G Medical Innovations is an Ideal Blend of Growth and Profitability

Newegg Commerce

Exela Technologies

Trxade Group

Taiwan Liposome Company Ltd - ADR

Looking for the next AMC, retail investors are on the hunt for the next squeeze. Here are five short squeeze stocks to watch this week.

Short Squeeze Stocks: XELA, NEGG and 3 Other Stocks Experts Think Are Ready to Pop

ARCA biopharma

BioDelivery Sciences

Dare Bioscience

Jaguar Health

Luokung Technology Corp

Are these Reddit penny stocks the best 7 to watch in July 2021? The post Best Reddit Penny Stocks to Buy Now?

Best Reddit Penny Stocks to Buy Now? 7 for Your July Small-Caps List

TEL AVIV and NEW YORK , June 29, 2021 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, today announced the closing of its previously announced underwritten initial public offering of 3,000,000 units, each consisting of one ordinary share and one warrant to purchase one ordinary share, at a combined public offering price of $5.00 per unit for aggregate gross proceeds of approximately $15.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. The ordinary shares and warrants began trading on the Nasdaq Capital Market on June 25, 2021 under the symbols “GMVD” and “GMVDW,” respectively.

News for G Medical Innovations Holdings Ltd Stock (GMVD)